Endothelial progenitor cell dysfunction in acute exacerbation of chronic obstructive pulmonary disease

Molecular Medicine Reports

Volumn 16, Issue 4, 2017, Pages 5294-5302

  Liu, Xiaoran ^a   Liu, Yangli ^b   Huang, Xinyan ^b   Lin, Gengpeng ^b   Xie, Canmao ^b  

^a HAINAN MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Acute exacerbation of chronic obstructive pulmonary disease; C X C chemokine receptor 4; Cardiovascular disease; Dysfunction; Endothelial progenitor cells

Indexed keywords

C REACTIVE PROTEIN; CHEMOKINE RECEPTOR CXCR4; MATRIGEL; STROMAL CELL DERIVED FACTOR 1ALPHA; COLLAGEN; LAMININ; PLATELET ENDOTHELIAL CELL ADHESION MOLECULE 1; PROTEOGLYCAN;

ACUTE DISEASE; AGED; ARTICLE; CARDIOVASCULAR RISK; CELL ADHESION; CELL COUNT; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DISEASE EXACERBATION; ENDOTHELIAL PROGENITOR CELL; FEMALE; HUMAN; HUMAN CELL; MALE; VASCULAR ENDOTHELIUM; ANGIOGENESIS; CFU COUNTING; DRUG COMBINATION; DRUG EFFECT; METABOLISM; PATHOLOGY; PHENOTYPE; UMBILICAL VEIN ENDOTHELIAL CELL;

AGED; C-REACTIVE PROTEIN; CELL ADHESION; CELL PROLIFERATION; CHEMOTAXIS; COLLAGEN; COLONY-FORMING UNITS ASSAY; DISEASE PROGRESSION; DRUG COMBINATIONS; ENDOTHELIAL PROGENITOR CELLS; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LAMININ; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; PLATELET ENDOTHELIAL CELL ADHESION MOLECULE-1; PROTEOGLYCANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, CXCR4;

EID: 85028716969     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2017.7260     Document Type: Article

References (32)

1. Niewoehner DE, Lokhnygina Y, Rice K, Kuschner WG, Sharafkhaneh A, Sarosi GA, Krumpe P, Pieper K and Kesten S: Risk indexes for exacerbations and hospitalizations due to COPD. Chest 131:20-28, 2007.
2. Chang CL, Robinson SC, Mills GD, Sullivan GD, Karalus NC, McLachlan JD and Hancox RJ: Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax 66:764-768, 2011.
3. Sin DD and Man SF: Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107:1514-1519, 2003.
4. Drost EM, Skwarski KM, Sauleda J, Soler N, Roca J, Agusti A and MacNee W: Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax 60:293-300, 2005.
5. Voelkel N and Taraseviciene-Stewart L: Emphysema: An autoimmune vascular disease? Proc Am Thorac Soc 2:23-25, 2005.
6. Karayama M, Inui N, Suda T, Nakamura Y, Nakamura H and Chida K: Antiendothelial cell antibodies in patients with COPD. Chest 138:1303-1308, 2010.
7. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA and Rafii S: Expression of VEGFR-2 and AC133 by circulating human CD34 (+) cells identifies a population of functional endothelial precursors. Blood 95:952-958, 2000.
8. Fadini GP, Agostini C, Sartore S and Avogaro A: Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 194:46-54, 2007.
9. Fischer D, Rossa S, Landmesser U, Spiekermann S, Engberding N, Hornig B and Drexler H: Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. Eur Heart J 26:65-69, 2005.
10. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M and Nickenig G: Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353:999-1007, 2005.
11. Liu Y, Liu X, Lin G, Sun L, Li H and Xie C: Decreased CD34+ cell number is correlated with cardiac dysfunction in patients with acute exacerbation of COPD. Heart Lung Circ 23:875-882, 2014.
12. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, et al: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176:532-555, 2007.
13. Celli BR and MacNee W; ATS/ERS Task Force: Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J 23:932-946, 2004.
14. de Wynter EA, Ryder D, Lanza F, Nadali G, Johnsen H, Denning-Kendall P, Thing-Mortensen B, Silvestri F and Testa NG: Multicentre European study comparing selection techniques for the isolation of CD34+ cells. Bone Marrow Transpla nt 23:1191-1196, 1999.
15. Liu X and Xie C: Human endothelial progenitor cells isolated from COPD patients are dysfunctional. Mol Cell Biochem 363:53-63, 2012.
16. Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR Goehring E Jr and She D: Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 16:63-70, 2006.
17. Lee HM, Lee J, Lee K, Luo Y, Sin DD and Wong ND: Relation between COPD severity and global cardiovascular risk in US adults. Chest 142:1118-1125, 2012.
18. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA, Jr., Enright PL, Kanner RE, O'Hara P, et al: Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. Jama 272:1497-1505, 1994.
19. Zvezdin B, Milutinov S, Kojicic M, Hadnadjev M, Hromis S, Markovic M and Gajic O: A postmortem analysis of major causes of early death in patients hospitalized with COPD exacerbation. Chest 136:376-380, 2009.
20. Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S and Eisner MD: COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser permanente medical care program. Chest 128:2068-2075, 2005.
21. Chiang CH, Huang PH, Chung FP, Chen ZY, Leu HB, Huang CC, Wu TC, Chen JW and Lin SJ: Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease. PLoS One 7:e31799, 2012.
22. Shantsila E, Watson T and Lip GY: Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 49:741-752, 2007.
23. Toshner M, Voswinckel R, Southwood M, Al-Lamki R, Howard LS, Marchesan D, Yang J, Suntharalingam J, Soon E, Exley A, et al: Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. Am J Respir Crit Care Med 180:780-787, 2009.
24. Palange P, Testa U, Huertas A, Calabrò L, Antonucci R, Petrucci E, Pelosi E, Pasquini L, Satta A, Morici G, et al: Circulating haemopoietic and endothelial progenitor cells are decreased in COPD. Eur Respir J 27:529-541, 2006.
25. Takahashi T, Suzuki S, Kubo H, Yamaya M, Kurosawa S and Kato M: Impaired endothelial progenitor cell mobilization and colony-forming capacity in chronic obstructive pulmonary disease. Respirology 16:680-687, 2011.
26. Liu X, Tan W, Liu Y, Lin G and Xie C: The role of the β2 adrenergic receptor on endothelial progenitor cells dysfunction of proliferation and migration in chronic obstructive pulmonary disease patients. Expert Opin Ther Targets 17:485-500, 2013.
27. Aguila HL: Regulation of hematopoietic niches by sympathetic innervation. Bioessays 28:687-691, 2006.
28. Petit I, Jin D and Rafii S: The SDF-1-CXCR4 signaling pathway: A molecular hub modulating neo-angiogenesis. Trends Immunol 28:299-307, 2007.
29. Stellos K, Langer H, Daub K, Schoenberger T, Gauss A, Geisler T, Bigalke B, Mueller I, Schumm M, Schaefer I, et al: Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothe-lial progenitor cells. Circulation 117:206-215, 2008.
30. Newman PJ and Newman DK: Signal transduction pathways mediated by PECAM-1: New roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 23:953-964, 2003.
31. Zocchi MR and Poggi A: PECAM-1, apoptosis and CD34+ precursors. Leuk Lymphoma 45:2205-2213, 2004.
32. Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, Wang CH, Badiwala MV, Mickle DA, Weisel RD, Fedak PW, et al: C-reactive protein attenuates endothelial progenitor cell survival, differentiation and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109:2058-2067, 2004.